Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Equity Ratio (2016 - 2019)

Historic Equity Ratio for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to 0.52.

  • Soleno Therapeutics' Equity Ratio rose 1248.42% to 0.52 in Q3 2019 from the same period last year, while for Sep 2019 it was 0.52, marking a year-over-year increase of 1248.42%. This contributed to the annual value of 0.7 for FY2018, which is 255.76% up from last year.
  • Per Soleno Therapeutics' latest filing, its Equity Ratio stood at 0.52 for Q3 2019, which was up 1248.42% from 0.41 recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Equity Ratio registered a high of 0.89 during Q1 2017, and its lowest value of 1.12 during Q1 2015.
  • Its 5-year average for Equity Ratio is 0.41, with a median of 0.61 in 2019.
  • In the last 5 years, Soleno Therapeutics' Equity Ratio soared by 48808.03% in 2016 and then tumbled by 4763.64% in 2018.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Equity Ratio stood at 0.39 in 2015, then soared by 57.04% to 0.62 in 2016, then rose by 11.33% to 0.69 in 2017, then rose by 2.56% to 0.7 in 2018, then decreased by 26.48% to 0.52 in 2019.
  • Its last three reported values are 0.52 in Q3 2019, 0.41 for Q2 2019, and 0.61 during Q1 2019.